Key statistics
As of last trade, Vigil Neuroscience Inc (VIGL:NSQ) traded at 3.21, 29.96% above the 52 week low of 2.47 set on Jun 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.98 |
---|---|
High | 3.25 |
Low | 2.98 |
Bid | 3.16 |
Offer | 3.21 |
Previous close | 3.00 |
Average volume | 70.87k |
---|---|
Shares outstanding | 40.88m |
Free float | 32.45m |
P/E (TTM) | -- |
Market cap | 122.64m USD |
EPS (TTM) | -2.07 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 19:41 GMT.
More ▼
- Vigil Neuroscience to Present at Upcoming Investor Conferences
- Vigil Neuroscience Reports Third Quarter 2024 Financial Results and Provides Business Update
- Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference
- Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927
- Vigil Neuroscience to Present at Cantor Global Healthcare Conference
- Vigil Neuroscience to Present at Upcoming September Investor Conferences
- Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
- Vigil Neuroscience Highlights Publication on ALSP Genetic Mutation Prevalence in Neurology Genetics
- Vigil Presents Data on its Small Molecule TREM2 Agonist Program at 2024 Alzheimer's Association International Conference (AAIC)
- Vigil Neuroscience Announces Interim Data from its Ongoing Phase 1 Clinical Trial Evaluating VG-3927 in Healthy Volunteers Supporting Continued Development in Alzheimer’s Disease
More ▼